ACCESS Newswire

Photonis Scientific, Inc.

23.5.2023 15:02:26 CEST | ACCESS Newswire | Press release

Share
Photonis Expands Market-Leading Mass Spectrometry Detection Technology

Visit Photonis at booth #407 during the 71st ASMS Conference

STURBRIDGE, MA / ACCESSWIRE / May 23, 2023 / Photonis has announced that the company will be exhibiting at the 71st American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, taking place June 4 - June 8, 2023, at the George R. Brown Convention Center in Houston, TX.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
ASMS



Photonis can be found at booth 407 in the exhibitor hall. Attendees are encouraged to meet and speak to the company's diverse team of technical experts and learn more about how their industry-leading MS Detection Technology will benefit new applications in Mass Spectrometry due to unprecedented performance levels.

At this occasion, Photonis, the leaders in Time-of-Flight (TOF) detection technologies, will showcase their latest advancements in TOF detection with additions to their existing detector platforms - the APTOF and BPTOF Series.

Photonis presents the APTOF A300, a capacitively-coupled, compact assembly detector designed for small footprint and/or benchtop TOF systems. The APTOF A300 integral AC-coupled high voltage isolation prevents damage to the digitizer and provides MS Instrument manufacturers with significant cost savings.

In parallel, the company will introduce the BPTOF B380, an optically coupled Bi-Polar TOF detector with never-before-seen lifetime benefits, based on a patented technology from Photonis.

Ulrich Laupper, President and General Manager of Photonis' Ultimate Detection Business Unit:

"We are excited to introduce the next generation of Time-of-Flight detection technology at this year's ASMS Conference. Photonis is committed to extensive investments into Research and Development activities in order to provide our industry partners market-leading detector solutions. The APTOF A300 and BPTOF B380 provide mass spectrometry instrument manufacturers an unmatched cost-of-ownership value proposition. In addition, it also enables them to offer new advanced applications to their end users. We are very proud to be part of the ASMS community and contribute to advance science and quality of life with our technologies."

Photonis' Time-of-Flight detectors support some of the world's most sensitive TOF-MS applications. Their patented technologies and distinct Microchannel Plates ensure optimum temporal resolution, excellent mass sensitivity, unmatched lifetime and superb dynamic range; enabling mass spectrometers to be optimized with the best detector on the market, no matter the analysis requirements. Photonis specializes in working in partnership with TOF-MS Instrument designers to understand the requirements needed in each instrument to provide the longest-lasting, accurate detectors specifically designed for each instrument.

About Photonis

Photonis is a market-leading provider of technologies used in the detection and amplification of photons, ions, electrons, and neutrons. We innovate and engineer the highest quality technology solutions for integration into a wide variety of applications, such as mass spectrometry, night vision optics, digital cameras, nuclear instrumentation, life-science and physics research, space exploration, and many others. With over 80 years of experience in partnering with our customers to provide the world's leading detection systems, Photonis has the experience to meet the specific challenges of the many markets we serve.

For more information, please contact us or visit us at booth #407 during the conference.

Related Image

Contact Information

Nicole Poirier
Marketing Manager
n.poirier@usa.photonis.com

SOURCE: Photonis

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/756322/Photonis-Expands-Market-Leading-Mass-Spectrometry-Detection-Technology

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

QorusDocs Named LegalTech AI Platform of the Year and Ranked No. 1 Proposal Management Software17.11.2026 15:00:00 CET | Press release

BELLEVUE, WA / ACCESS Newswire / November 17, 2026 / QorusDocs, the pursuit intelligence platform trusted by dozens of Am Law 200 and Global 200 law firms, today announced it has been named LegalTech AI Platform of the Year in the seventh annual LegalTech Breakthrough Awards program and ranked the No. 1 proposal management solution by Info-Tech Research Group's SoftwareReviews, based on verified end-user reviews. The recognitions cap a year of rapid growth in legal for QorusDocs, which forecasts it will double its annual recurring revenue (ARR) from law firms in the next 12 months by adding more high-profile firms to its list of big law customers, which already includes DLA Piper, Baker McKenzie, Herbert Smith Freehills Kramer and Womble Bond Dickinson. Firms are moving AI beyond research and drafting and into business development, where a winning pitch depends on the best representative matters, strong attorney biographies and winning pitch strategies: knowledge general AI tools lack.

Freezz Italia Awarded ESA Contract for IRIS(2) Low-LEO Pre-Operational and De-Risk Activities17.11.2026 14:00:00 CET | Press release

CORTONA, IT / ACCESS Newswire / November 17, 2026 / Freezz Italia has been awarded a contract by the European Space Agency (ESA), as prime contractor leading a European industrial consortium, for the Consolidation Phase of the IRIS² Low-LEO Pre-Operational and De-Risk Activities, part of the ESA Programme Related to EU Secure Connectivity. The activity will further mature Friisat, Freezz's satellite system architecture conceived specifically for operation in Very Low Earth Orbit (VLEO) and designed for future broadband Direct-to-Device (D2D) connectivity within the 3GPP 5G/6G Non-Terrestrial Network (NTN) framework. Under this ESA contract, Freezz Italia will consolidate the mission and system architecture, adapting Friisat's existing commercial design to meet the requirements of an IRIS²-compatible solution, including future governmental broadband Direct-To-Device secure-connectivity services. The work will address the system and service concepts, architecture and interfaces, security

International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital17.11.2026 11:00:00 CET | Press release

PARIS, FR / ACCESS Newswire / November 17, 2026 / Opti Digital, the leading AdTech company specialising in publisher revenue optimisation, today announced the results of its collaboration with International Business Times UK, an international digital news brand delivering business, markets, technology and current affairs coverage to a global readership. Operating in a fast-moving news environment, International Business Times UK continuously explores opportunities to increase the value of its digital audience while maintaining control over advertising quality and user experience. The publisher identified an opportunity to generate incremental revenue from its existing audience and inventory through a monetisation experience that could be tested progressively and scaled across a broader share of its inventory. "We were looking for ways to generate more value from our existing inventory, and the performance quickly demonstrated the potential of the new experience. It has become a meaning

OBI Pharma Signs Collaboration and License Agreement with Novartis16.11.2026 09:10:00 CET | Press release

TAIPEI, TW / ACCESS Newswire / November 16, 2026 / OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for selected, undisclosed Novartis payload classes. In parallel, under the collaboration OBI will evaluate novellinker approaches with the Novartis payloads. Novartis will further have the option to expand the agreement to include additional novel payload classes. This agreement marks an important milestone for OBI and underscores the value of its differentiated ADC technology platform. The agreement recognizes the potential of OBI's proprietary technologies, including GlycOBI®, EndoSymeOBI®, HYPrOBI®, an

Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q213.11.2026 13:30:00 CET | Press release

MIAMI, FL / ACCESS Newswire / November 13, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(Cboe Canada:DGX) ("Digi Power X" or the "Company"), an AI data center infrastructure operator, today reported its financial and operating results for the third quarter ended September 30, 2026 (all amounts in U.S. dollars, unless otherwise indicated). The Company's quarterly report on Form 10-Q, which includes unaudited consolidated financial statements and management's discussion and analysis ("MD&A") for the quarter ended September 30, 2026, is being filed and made accessible under the Company's continuous disclosure profile on SEDAR+ at www.sedarplus.ca and will also be available on EDGAR at www.sec.gov/edgar. Third Quarter 2026 Highlights All amounts in U.S. dollars (millions) Revenue of $12.25 million, up 85% from the previously completed fiscal quarter and an increase of 50% compared to the quarter ended September 30, 2025; $119.6 million in cash, cash equivalents and digital currencies, $103.0 mill

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye